These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30303663)

  • 1. [INTESTINAL MICROBIOTA: ITS ROLE IN PATHOGENESIS OF ARTERIAL HYPERTENSION].
    Aitbaev KA; Murkamilov IE
    Klin Med (Mosk); 2017; 95(2):123-6. PubMed ID: 30303663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.
    Qi Y; Kim S; Richards EM; Raizada MK; Pepine CJ
    Circ Res; 2017 May; 120(11):1724-1726. PubMed ID: 28546357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [COMPARATIVE EXPERIMENTAL EVALUATION OF THE EFFECTIVENESS OF MODERN PROBIOTICS, PREBIOTICS, SYNBIOTICS AND METABIOTICS FOR CORRECTION OF INTESTINAL MICROBIOCENOSIS IN ANIMALS WITH ANTIBIOTIC-ASSOCIATED DYSBIOSIS].
    Chicherin IY; Pogorelsky IP; Lundovskikh IA; Darmov IV; Shabalina MR; Podvolotsky AN
    Eksp Klin Gastroenterol; 2016; (7):106-20. PubMed ID: 30284433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
    Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
    Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
    Pearson JS; Whorwell PJ
    Curr Opin Gastroenterol; 2017 Jan; 33(1):21-25. PubMed ID: 28134688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The gut microbiota, a new cardiovascular risk factor?].
    Chong-Nguyen C; Duboc H; Sokol H
    Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human microbiome restoration and safety.
    Daliri EB; Tango CN; Lee BH; Oh DH
    Int J Med Microbiol; 2018 Jul; 308(5):487-497. PubMed ID: 29773467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies.
    Kang Y; Cai Y
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):110-117. PubMed ID: 29102544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
    Konturek PC; Zopf Y
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota Dysbiosis in Postweaning Piglets: Understanding the Keys to Health.
    Gresse R; Chaucheyras-Durand F; Fleury MA; Van de Wiele T; Forano E; Blanquet-Diot S
    Trends Microbiol; 2017 Oct; 25(10):851-873. PubMed ID: 28602521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut dysbiosis is linked to hypertension.
    Yang T; Santisteban MM; Rodriguez V; Li E; Ahmari N; Carvajal JM; Zadeh M; Gong M; Qi Y; Zubcevic J; Sahay B; Pepine CJ; Raizada MK; Mohamadzadeh M
    Hypertension; 2015 Jun; 65(6):1331-40. PubMed ID: 25870193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate effects of antibiotics on hypertension.
    Galla S; Chakraborty S; Cheng X; Yeo J; Mell B; Zhang H; Mathew AV; Vijay-Kumar M; Joe B
    Physiol Genomics; 2018 Oct; 50(10):837-845. PubMed ID: 30095376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J; De Cruz P
    Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota changes and chronic hepatitis C virus infection.
    Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of gut microbiota in tumorigenesis and treatment.
    Xu JY; Liu MT; Tao T; Zhu X; Fei FQ
    Biomed Pharmacother; 2021 Jun; 138():111444. PubMed ID: 33662679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The human intestinal microbiome and why you have to think twice before prescribing antibiotics!].
    Hiergeist A; Gessner A
    MMW Fortschr Med; 2018 Jan; 160(1):58-62. PubMed ID: 29335940
    [No Abstract]   [Full Text] [Related]  

  • 20. Probiotics as Beneficial Dietary Supplements to Prevent and Treat Cardiovascular Diseases: Uncovering Their Impact on Oxidative Stress.
    Vasquez EC; Pereira TMC; Peotta VA; Baldo MP; Campos-Toimil M
    Oxid Med Cell Longev; 2019; 2019():3086270. PubMed ID: 31205584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.